Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,545 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,124
Recruiting: 1,216
Ph III recruiting: 129
Growth YoY: +12.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (885)

clinicaltrialsPublishedShowing 351–400 of 2,675 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05945823	Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors	active not recruiting	Phase 2	53	Taiho Oncology, Inc.INDUSTRY	4	Sep 1, 2026	clinicaltrials
NCT06294548	A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC	recruiting	Phase 1 / Phase 2	45	University of Alabama at BirminghamOTHER	1	Sep 1, 2026	clinicaltrials